REATA PHARMACEUTICALS Trademark

Trademark Overview

On Monday, October 5, 2015, a trademark application was filed for REATA PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the REATA PHARMACEUTICALS trademark a serial number of 86778681. The federal status of this trademark filing is REGISTERED as of Tuesday, January 23, 2018. This trademark is owned by Reata Pharmaceuticals, Inc.. The REATA PHARMACEUTICALS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and for use in oncology, ophthalmology, and the prevention and treatment of gastrointestinal diseases, diseases and disorders of the immune system including autoimmune diseases, and skin diseases
reata pharmaceuticals

General Information

Serial Number86778681
Word MarkREATA PHARMACEUTICALS
Filing DateMonday, October 5, 2015
Status700 - REGISTERED
Status DateTuesday, January 23, 2018
Registration Number5387142
Registration DateTuesday, January 23, 2018
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 5, 2016

Trademark Statements

Description of MarkThe mark consists of nine dots, the outer corners dark gray, the center dot light gray, and the remaining dots blue, all forming a square to the left of the words "REATA PHARMACEUTICALS" in dark gray in all caps.
Goods and ServicesPharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and for use in oncology, ophthalmology, and the prevention and treatment of gastrointestinal diseases, diseases and disorders of the immune system including autoimmune diseases, and skin diseases
Indication of Colors claimedThe color(s) blue, dark gray and light gray is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text"PHARMACEUTICALS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 8, 2015
Primary Code005
First Use Anywhere DateMonday, October 31, 2016
First Use In Commerce DateMonday, October 31, 2016

Trademark Owner History

Party NameReata Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPlano, TX 75024
Party NameReata Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIrving, TX 75063
Party NameReata Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIrving, TX 75063

Trademark Events

Event DateEvent Description
Tuesday, January 23, 2024TEAS SECTION 8 & 15 RECEIVED
Wednesday, May 24, 2023ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Monday, January 23, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, October 12, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, October 12, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 12, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 12, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 12, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, January 23, 2018REGISTERED-PRINCIPAL REGISTER
Thursday, December 21, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, December 20, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, December 12, 2017STATEMENT OF USE PROCESSING COMPLETE
Wednesday, November 29, 2017USE AMENDMENT FILED
Tuesday, December 12, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, November 29, 2017TEAS STATEMENT OF USE RECEIVED
Friday, June 2, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 31, 2017SOU EXTENSION 2 GRANTED
Wednesday, May 31, 2017SOU EXTENSION 2 FILED
Wednesday, May 31, 2017SOU TEAS EXTENSION RECEIVED
Friday, December 2, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 30, 2016SOU EXTENSION 1 GRANTED
Wednesday, November 30, 2016SOU EXTENSION 1 FILED
Wednesday, November 30, 2016SOU TEAS EXTENSION RECEIVED
Tuesday, May 31, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 5, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 5, 2016PUBLISHED FOR OPPOSITION
Wednesday, March 16, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, March 2, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, March 2, 2016ASSIGNED TO LIE
Thursday, January 28, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 28, 2016EXAMINER'S AMENDMENT ENTERED
Thursday, January 28, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, January 28, 2016EXAMINERS AMENDMENT E-MAILED
Thursday, January 28, 2016EXAMINERS AMENDMENT -WRITTEN
Monday, January 25, 2016ASSIGNED TO EXAMINER
Friday, October 9, 2015NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, October 8, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 8, 2015NEW APPLICATION ENTERED

Related Keywords

pharmaceuticals reata system diseases disorders treatment prevention ophthalmology gastrointestinal immune autoimmune skin